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ABSTRACT
RNA interference (RNAi) is a phylogenetically conserved gene regulation mechanism that
modulates a wide variety of biological functions through suppressing gene expression at
transcriptional or posttranscriptional levels (Bass 2000; Sharp 2001). One of the major natural
functions of RNAi is antiviral defense in cytosol. RNAi directed viral immunity (RDVI) targets
viral transcripts for destruction using small interfering RNAs (siRNAs) processed from viral
replication intermediates, in the form of double-stranded RNA (dsRNA), as sequence guide (Lu,
Maduro et al. 2005). Accumulating evidence suggests RDVI in the nematode worm
Caenorhabditis elegans begins with the biogenesis of virus-derived siRNAs (viRNAs) by DCR1 (Bernstein, Caudy et al. 2001; Duchaine, Wohlschlegel et al. 2006), a type III ribonuclease,
and RDE-4, a dsRNA binding protein (Grishok, Pasquinelli et al. 2001; Knight and Bass 2001).
Efficient destruction of viral transcripts guided by viRNAs is then orchestrated by several host
factors that form distinct classes. Some of the known host factors downstream of viRNA
biogenesis include Argonaute proteins (e.g. RDE-1) (Tabara, Sarkissian et al. 1999; Hammond,
Boettcher et al. 2001; Parrish and Fire 2001), RNA-dependent RNA polymerases (e.g. RRF-1)
and putative RNA helicases (e.g. DRH-1) (Tabara, Sarkissian et al. 1999).
To better understand worm RDVI, we have recently performed a genetic screen aiming to
isolate novel host factors in the RDVI pathway. RSD-2 is one of our top candidates whose
function in RDVI has been confirmed using corresponding genetic mutants in this study. RSD-2
is a novel protein that is not conserved in fungi, plants, insects or vertebrates (Tijsterman and
viii

Plasterk 2004). When the level of viral replication was accessed in double mutants that contain
both the rsd-2 null allele and null allele corresponding to rde-1, rde-4 or drh-1, enhanced viral
replication, as compared to respective single mutants, was observed. Since viRNAs can be
readily detected in double mutants corresponding to rde-4;rsd-2, these observations together
suggested that RSD-2 functions in a RDE-4-independent pathway for virus silencing. Since
RSD-2 appears to be unique to the nematode kingdom, our study on the function and mechanism
of RSD-2 may help reveal some unique features of the worm RDVI.
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CHAPTER ONE: INTRODUCTION
1.1 C. elegans as a Model Organism
C. elegans is a type of free-living nematode, typically 1 mm in-length, which feeds on
bacteria, usually E. coli species (Wood 1988). They can be maintained in the lab by growing on
agar plates with the E. coli as the food source (Stiernagle 2006). C. elegans has been one of the
model organisms for research on biological sciences since 1974 (Epstein, Waterston et al. 1974;
Waterston, Epstein et al. 1974).

Figure 1.1 The anatomy of C. elegans (Girard, Fiedler et al. 2007). The hermaphrodites and
males are different in their body size and structures such as the somatic gonad and tail.
Numerous other tissues and organs are sexually dimorphous, especially the nervous system and
musculature.

The basic anatomy of C. elegans includes mouth, pharynx, intestine, gonad, and
collagenous cuticle (Riddle 1997). C. elegans has two sexes: hermaphrodites and males (Riddle
1997). Hermaphrodites have two ovaries, oviducts, spermatheca, and a single uterus (Riddle
1997). Males have a single-lobed gonad, vas deferens, and a tail specialized for mating. C.
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elegans has five pairs of autosomes and one pair of sex chromosomes (Riddle 1997).
Hermaphrodite C. elegans has a pair of sex chromosomes (XX), but the males have only one sex
chromosome (X0) (Riddle 1997). Hermaphrodites can be maintained by self-fertilizing, and
males can be produced by heat shock at 42 °C for around 45 minutes and maintained by crossing
with hermaphrodites. Self-fertilized hermaphrodites can lay approximately 300 eggs, while the
number can be above 1, 000 when fertilized by a male (Riddle 1997).
At 20 °C, C. elegans has an average life span of 2-3 weeks, and it needs around 14 hours,
12 hours, 8 hours, 8 hours, 10 hours, and 8 hours to grow from embryonic development-L1-L2L3-L4-young adult-adult. For special, when stresses such as crowding or food limitation
condition is encountered, L1 animals can enter into the dauer stage in which animals can survive
without food for several months, and after the stresses disappear, the worms staying at the dauer
stage can bypass both L2 and L3 stages and get into the L4 stage directly (Cassada and Russell
1975; Albert and Riddle 1988).

Figure 1.2 The life span of C. elegans at 20 °C (Girard, Fiedler et al. 2007). C. elegans has a
short life cycle. The life cycle is temperature-dependent. C. elegans goes through a reproductive
life cycle (egg to adult) in 5.5 days at 15°C, 3.5 days at 20°C, and 2.5 days at 25°C.
2

The genomic sequence of C. elegans was obtained and published in 1998 (1998), and the
remaining gaps were finished by 2002. The C. elegans genome sequence is approximately 100
million base pairs long (Wood 1988).
Mutant C. elegans strains can be obtained through treatment of chemical mutagen such as
Ethyl Methanesulfonate (EMS) or exposure to ionizing radiation (Epstein, Shakes et al. 1995;
Jorgensen and Mango 2002), followed by genetically crossing with wild type C. elegans strain
for several times to remove the possible undesired mutated genes based on the extent of used
mutagenesis, and self-crossing to obtain the homozygous strain. Genetic cross among
homozygous C. elegans with different genetic backgrounds can facilitate separation or
combination of different genetic background to bring about new C. elegans strains with the
genetic background we are interested in from their descendants. Transgenic C. elegans strains
can be created through injection of the designed plasmid constructs to animals’ gonads followed
by picking the desired strain from the next generation of treated animals (Mello, Kramer et al.
1991). There is a large collection of C. elegans genetic mutants, and they can be ordered from
the Caenorhabditis Genetics Center (CGC) or be asked from the labs which generated those
mutants (Rogers, Antoshechkin et al. 2008).
C. elegans genes can be down-regulated using many different procedures such as feeding
worms with the bacteria producing corresponding dsRNAs, transforming the worm with the
sequence which can be transcribed as dsRNAs, or artificially introducing synthesized dsRNAs
into animals by either soaking or injection (Jose and Hunter 2007).
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Figure 1.3 Illustration of strategies for down-regulating genes in C. elegans (Jose and
Hunter 2007). (A) Feeding the worms with transgenic bacteria expressing dsRNAs
complementary to the gene of interest. (B) Worms can be made transgenic to produce specific
dsRNAs in vivo. (C) Synthesized dsRNAs can be introduced to worms through either injection
or soaking.
1.2 RNA Interference
RNA interference (RNAi), or RNA silencing is a novel mechanism found in eukaryotic
cells that regulates gene expressions (Hammond, Caudy et al. 2001; McManus and Sharp 2002;
Tomari and Zamore 2005), and three main types of small RNAs, microRNA (miRNA), small
interfering RNA (siRNA), and piwi-interacting RNA (piRNA), were found to play important
roles in different RNAi pathways (Xie, Johansen et al. 2004; Ruby, Jan et al. 2006).
For siRNA-mediated RNAi pathway, RNAi is initiated by dsRNA (Fire, Xu et al. 1998).
Subsequently, dsRNAs will be diced by Dicers into short fragments of 20-30 nts called small
interference RNAs (siRNAs) (Ding and Voinnet 2007; Aliyari and Ding 2009). Thereafter, the
passenger strand will be degraded and the guide strand will be incorporated into the RNAinduced silencing complex (RISC) for target selection, eventually resulting in either degradation
4

or translation arrest of the targets based on the extent of sequence complementarities between the
guide strand and its targets (Hammond, Bernstein et al. 2000; Hammond 2005). Some organisms
such as plants and C. elegans are able to produce RNA-dependent RNA polymerases (RdRPs), a
class of enzymes responsible for generation of secondary siRNAs, which can also silence target
transcript expression (Sijen, Fleenor et al. 2001; Pak and Fire 2007; Sijen, Steiner et al. 2007).
As a result, RNAi in these organisms is very efficient despite the initially small amount of
siRNAs, unlike organisms, such as mammals, which do not produce RdRPs. In addition, some
organisms have structure channels between adjacent cells, e.g. plasmodesmata in plants, or
protein channels in cell membranes, e.g. SID-1 protein in C. elegans, causing RNAi silencing
signals being able to travel from cell to cell. Consequently, RNAi in these organisms is capable
of spreading systemically.
Naturally, RNAi-related mechanisms contribute to development, transposon control, and
antiviral silencing (Grishok, Pasquinelli et al. 2001; Boutet, Vazquez et al. 2003). Since the
silencing effect is highly specific and robust, RNAi has been used as a genetic tool to suppress
the expression of genes of our interest, mainly through introducing corresponding artificial
dsRNAs into cell cultures or living organisms. Moreover, RNAi has also been used in reverse
genetic to identify genes required for a particular cellular pathway or an event by systemically
silencing each gene in the cell in a large-scale genetic screen.
In C. elegans, RNAi was known as efficient, transitive and systemic, and it can be induced
by feeding, soaking, or injecting the organism with exogenous dsRNA, or through integrating the
DNA sequence, which is able to generate dsRNA after transcription, into worm’s genome
(Figure 1.3).
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1.3 RNAi Directed Viral Immunity (RDVI)
Antiviral defense is one of the natural functions of RNAi (Boutet, Vazquez et al. 2003;
Ding, Li et al. 2004; Deleris, Gallego-Bartolome et al. 2006; Wang, Aliyari et al. 2006).
Infecting viruses in organisms can generate long dsRNAs during the viral replication. In plants
and invertebrates, Dicers will cleave viral dsRNAs into short fragments of viral siRNAs
(viRNAs), which are structurally similar to the siRNA duplex intermediate (Boutet, Vazquez et
al. 2003). Afterward, one strand of the viRNA duplex will be loaded into RNA induced silencing
complex (RISC) and used as sequence guide to find its complementary targets, the viral RNA
transcripts. Consequently, the catalytic component of RISC, Argonaute protein will cleave the
viral transcripts, resulting in the silencing of replicating viruses (Vastenhouw and Plasterk 2004).
In some organisms such as plants and nematodes, the production of secondary viRNAs by the
organisms’ own RdRPs can bring about great increase of the amounts of viRNAs available to
RISC, leading to the silencing effect of antiviral RNAi being further amplified (Aoki, Moriguchi
et al. 2007; Diaz-Pendon, Li et al. 2007).
1.4 Flock House Virus (FHV)
We choose FHV as our model virus because FHV can replicate in yeast, plant, insect and
mammalian cells and it is one of the well-studied viruses (Johnson and Ball 1999; Venter and
Schneemann 2008). FHV contains two genomic segments, RNA1, which encodes the viral RNA
dependent RNA polymerase (RdRP) (Figure 1.4A) and RNA2, which encodes precursor protein
of the viral coating protein (Figure 1.4B). RNA1 can replicate autonomously in the absence of
RNA2 whose replication is dependent on RNA1. At the 3' end of RNA1, there is a subgenomic
RNA3 which is transcribed during RNA1 replication from an internal site of the complementary,
6

replicative intermediate of RNA1 (Figure 1.4A). RNA3 is not required to initiate FHV infection
and it encodes the RNAi suppressor protein B2.

Figure 1.4 Genomic structure of Flock House Virus. (A) Expression of wild type FHV RNA1
(FR1) produces FHV RdRP and expression of FHV RNA3 (FR3) produces RNAi suppressor B2
protein of FHV. (B) Expression of wild type FHV RNA2 (FR2) produces the precursor protein
of FHV.
1.5 Orsay Virus
Orsay virus is a novel RNA virus distantly related to known nodaviruses, and it was
isolated from wild C. elegans strain JU1580 with abnormal morphological phenotypes in
intestinal cells (Felix, Ashe et al. 2011). RT-PCR assay and Illumina/Solexa high-throughput
sequencing were utilized to confirm the presence of Orsay virus in the infected animals, and Orsay

viral RNA was detected in intestine and somatic gonad, through fluorescent in situ hybridization
(FISH) using a probe complementary to the sense RNA1 segment of Orsay virus (Felix, Ashe et
al. 2011). The observation that Orsay virus infection invokes a small RNA response in JU1580
animals indicates RNAi mechanisms provide antiviral immunity to C. elegans and Orsay virus
infection of mutant animals can be used to confirm genes essential for antiviral defense (Felix,
Ashe et al. 2011). Also, the observation that Orsay virus accumulation increases in RNAi mutant
strains, compared to that in wild type N2 worms, provides a completely natural setting to
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demonstrate the roles of RDVI in C. elegans. Thus, all of our results were confirmed through
Orsay virus infection.
The genomic structure of Orsay nodavirus is very similar to that of FHV. The genomic
structure of Orsay nodavirus is very similar to that of FHV. Both viruses contain two genomic
segments, RNA1 which encodes RNA dependent RNA polymerase, and RNA2 which encodes
the precursor protein of viral coating protein at its 5' end. However, no predicted RNA3 sequence
was found at the 3’ end of Orsay virus RNA1; instead, it seems that there is another open reading
frame at 3’ end of Orsay virus RNA2. For detection of Orsay virus infection, we prepared cDNA
probes that are complementary to the segment of Orsay virus RNA1.

Figure 1.5 Schematic of genomic organization of Orsay virus (Felix, Ashe et al. 2011). The
RNA1 segment (2,680 nucleotides) encoded a predicted open reading frame of Orsay virus
RdRP, and the RNA2 segment was predicted to encode a capsid protein at its 5’ end as well as a
second ORF at the other end.
1.6 The rsd-2 Gene
Originally, rsd-2 was screened out as a gene required for RNAi spreading from somatic
cells to germline cells in C. elegans and the mutant animals showed no any development defect
(Tijsterman and Plasterk 2004). The observation that rsd-2 mutants showed phenotype when fed
with dsRNA against somatic genes, but not germline genes, indicates that rsd-2 mutants are
sensitive to RNAi against somatic genes, but not to RNAi targeting germline genes. In other
words, mutations in the rsd-2 gene do not affect somatic RNAi (Tijsterman and Plasterk 2004).
8

They don’t appear defective in the initial uptake of dsRNA from the gut into somatic tissues but
they fail to further distribute the dsRNA to the germline (Tijsterman and Plasterk 2004).
Later on, it was discovered that the function of rsd-2 in RNAi is very complex and
environmentally regulated. First, rsd-2 gene has mosaic effect in both somatic RNAi and
germline RNAi based on the observations after increasing the range of genes targeted by feeding
RNAi. Second, the rsd-2 mutants show environmentally sensitive defects in cell autonomous
RNAi elicited from transgene-delivered dsRNAs. Third, rsd-2 has essential roles in maintaining
chromosome integrity, such as transposon silencing in some unfavorable environment (Wang,
Aliyari et al. 2006).
RSD-2 protein is a novel protein with no close homolog found in other organisms, thus no
indication of its molecular function so far. RSD has an N-terminal domain that exists in three
copies (Tijsterman and Plasterk 2004). RSD-2 protein was found to exist in multiple cellular
compartments, including the nucleolus and cytoplasmic compartments, and to most frequently
interact with RSD-6 (Wang, Aliyari et al. 2006).
The rsd-2 gene is located on chromosome IV. Two alleles of rsd-2 were used in my study:
tm1429, which contains 451 base pair (bp) deletion, and pk3307, which contains a point
mutation(c to t) (Figure 1.6). The tm1429 allele was isolated using TMP/UV as mutagen by
Shohei Mitani’s lab at the Tokyo Women’s Medical College, and the pk3307 allele was isolated
using EMS as mutagen by Hubrecht Laboratory (Rogers, Antoshechkin et al. 2008).
The wild type RSD-2 coding sequence is shown below. Pink colored sequences are
flanking sequences, and capitalized sequences are deleted sequences in the tm1429 allele.

9

tcaacccaaaattctcacaaatctcttggtactgccatgtttagaaccattccgtggttcatttggaagccgagagatacttttcgcgccaagac
catttttcctgctcaattgataaatgttatcttcatattttcccattacttgcaagtaatgatccaagtcatcgatgaattgtcttttaagtggagctact
gctttgaaacatgctttcagtggatcaccgtattgtaccctgaaaaatccaaaaattaactttttttttgcattttgcagcattatacaacataaaaaa
cacgttttcaagatttagtggaaaacgagatctacgaaaatatgatctacgaaaagtggatctatcaaaacaagatctacattttcaggatctgg
cgtgccaacggcggttttcgcagttttctcgaagaaaatcgaaacaacgatgctccaatattatgcatcgcgcgttgtttagcgttttccagaag
tttttttttcaaaaaAAGCTTTTCTGGACGCTAAACAACGCGCGATGCGTAATTGTTTTGGTAGATCTCCAAATTGTA
GATCTTATTTTGGTAGATCTCCAAATTGTAGATCATGTTTTGGTAGATCTCCAAATTGTAGATATTGTTTTCG
TAAATCTTCTTTCCGTAGATCTTGTTTCCGGGTAAATCTTGAAAACGTGATGCCTCCTCGCTTACATTGTAAT
CTGAGTACTGTAGACGGTTCCAAATTCAAAATCTCCAGTTATTCGAGGAATCTCCACAAATCCATATCGATC
CGATACACCGACTTCCTTATTGTATGATTTGTGCTTTGGATTTGACGAGAAAATCACGTTTGCAGAGATCTTC
GGAACATCATCAGACGAGAAAACTGCCCCCTCACACTCTGAAACTCGTGCCGATTGAGTTTGAATCGACGTC
TTTCCATAATTATTTCCAGCCGCTACAGCCGCTAtgaactggaaaattccatatggacgaagtctgcaaagagttttgatgacat

tgaaaattggtgctcgccaactaacggaacggttactccagctgtgcaaattgtcataagcttcaactgagtcgtctcgaaaccgacacattc
gtcattgtccacgttgagcacaattacagaatgatctaccccgacttttgaagacgaaattgtggacgaacttgattcggacagagattgggg
cattcttccaaatgttctggaattaataaaaatatatgtttcaaattttatcgttttattggactcaaaattgcatgaaaacaccgaatttcttaatgaa
acttcttgaaaacttctctttaaaaaatttatggcggctcaaaaaatgactttaaattagttaaaatttgaaatttgaccaacttgtcaagtggctgg
aaactgattattaattatcatgagttttcaactcgatttaggtattttattttaaaaaaaaacca (Rogers, Antoshechkin et al.
2008)
The sequences of the plus strand of mutant rsd-2 in strain tm1429 are as followings.
tcaacccaaaattctcacaaatctcttggtactgccatgtttagaaccattccgtggttcatttggaagccgagagatacttttcgcgccaagac
catttttcctgctcaattgataaatgttatcttcatattttcccattacttgcaagtaatgatccaagtcatcgatgaattgtcttttaagtggagctact
gctttgaaacatgctttcagtggatcaccgtattgtaccctgaaaaatccaaaaattaactttttttttgcattttgcagcattatacaacataaaaaa
cacgttttcaagatttagtggaaaacgagatctacgaaaatatgatctacgaaaagtggatctatcaaaacaagatctacattttcaggatctgg
10

cgtgccaacggcggttttcgcagttttctcgaagaaaatcgaaacaacgatgctccaatattatgcatcgcgcgttgtttagcgttttccagaag
tttttttttcaaaaatgaactggaaaattccatatggacgaagtctgcaaagagttttgatgacattgaaaattggtgctcgccaactaacggaac
ggttactccagctgtgcaaattgtcataagcttcaactgagtcgtctcgaaaccgacacattcgtcattgtccacgttgagcacaattacagaat
gatctaccccgacttttgaagacgaaattgtggacgaacttgattcggacagagattggggcattcttccaaatgttctggaattaataaaaata
tatgtttcaaattttatcgttttattggactcaaaattgcatgaaaacaccgaatttcttaatgaaacttcttgaaaacttctctttaaaaaatttatggc
ggctcaaaaaatgactttaaattagttaaaatttgaaatttgaccaacttgtcaagtggctggaaactgattattaattatcatgagttttcaactcg
atttaggtattttattttaaaaaaaaacca (Rogers, Antoshechkin et al. 2008)

Figure 1.6 Genomic positions of the wild type rsd-2 gene and the rsd-2 mutant alleles
(Rogers, Antoshechkin et al. 2008). The tm1429 mutant allele contains a 451 bp deletion and
the pk 3307 mutant allele contains a nucleotide substitution of c to g.
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CHAPTER TWO: MATERIALS AND METHODS
2.1 C. elegans Genetics and Culture
All worm strains were propagated and maintained using standard protocols. The food for
the worms is prepared using E. coli strain OP50 or HT115. The Bristol strain N2 was used as the
standard wild-type strain. Alleles used in this study are all derived from N2 and include rde-1
(ne300), rde-4 (ne337), drh-1 (tm1329), drh-2 (ok951), rrf-1 (pk1417), ergo-1 (tm1860), and
rsd-2 (tm1429 and pk3307). The genotypes of the worm strains containing single or double
mutations were confirmed by PCR and/or feeding RNAi targeting skn-1. The strain used to
maintain Orsay virus is JU1580 from Dr. David Wang’s lab.
2.2 Transgenic Construct and Transgenic Worms
The FR1gfp replicon was derived from pFR1-3 through replacing most of the B2 coding
sequence (the nucleotides 2,802–3,001 of RNA1) by the full length enhanced GFP coding region
as described previously (Li, Li et al. 2004; Lu, Maduro et al. 2005). This method created a
translational fusion of GFP with N-terminal 23 amino acids of B2 and around 200 nucleotides
(nts) deletion from the B2 open reading frame. Transgenic animals carrying the FR1fp replicon
was generated by microinjecting into wild type strain with FR1fp, in which the 3’ end of
enhanced GFP coding sequence was used to replace B2 coding sequence in pFR1-3 instead of
the full length enhanced GFP sequence. Psur-5::GFP contains a constitutive sur-5 promoter
followed by full length enhanced GFP coding sequence. Similarly, Psur-5::RSD-2 contains wild
type RSD-2 coding sequence driven by the sur-5 promoter.
Animals were made transgenic by gonadal microinjection following standard protocol
(Mello, Kramer et al. 1991). Briefly, FR1gfp plasmid (final concentration 5 mg/ml) was mixed
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with the rol-6D plasmid pRF4 (final concentration 100 mg/ml) for injection into wild-type N2
animals. Integrated lines were then generated by treating about 50 transgenic hermaphrodites
with 3,500 rad of γ-rays from a 137Cs source, followed by screening for integrated animals in the
F2 generation.
2.3 Orsay Virus Infections
The Orsay virus stock was maintained using C. elegans isolate JU1580. To prepare Orsay
virus inoculum, Orsay virus particles was extracted by first washing off infected JU1580 animals
from 6 cm culture plates using distilled water. Then, the animals were precipitated by
centrifugation. Next, the virus containing supernatant solution was collected and filtered through
0.2 µm filters to remove other possible contaminants. At last, 5-10 times concentrated E. coli
solution was mixed with the filtered liquid, and aliquots were dropped on the middle of the agar
plates for culturing C. elegans strains. As soon as the Orsay virus containing E. coli food in the
culture plates becomes dry, worms can be grown in these plates for 2 to 3 days to be infected by
Orsay virus.
2.4 RNAi Experiments
Feeding RNAi targeting gfp or skn-1 was performed by feeding worms with E. coli food
which can express dsRNAs corresponding to gfp or skn-1 coding sequence respectively. IPTG at
final concentration of 2 mM was used for the induction of dsRNA expression.
2.5 RNA Preparation and Northern Blot Analysis
Total RNA was prepared using the TRI Reagent method (MRC, Inc.). RNA concentrations
were normalized and used for northern blot analysis according to standard protocols described
previously (Li, Li et al. 2002) using labeled cDNA probe corresponding to the 3’ end 387 nts of
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GFP, which will hybridize to both RNA1 and RNA3 of FHV. For high molecular weight viral
RNA detection, 3 to 6 µg total RNA per lane was loaded in 1.2% agarose gel. For small RNA
analysis, 10 to 20 µg of enriched small RNA samples per lane was resolved using 15%
acrylamide denaturing gel along with chemically synthesized DNA oligos as size references.
After electrophoreses, the RNA samples were transferred onto Hybond N+ membrane
(Amersham Bioscience) and UV cross-linked using 1800 µJ/cm2 as output power
(SpectroLinker). For northern blot detection of FHV and full length GFP transcripts, cDNA
probes were prepared by labeling GFP DNA fragments using AlkPhos Direct Labeling Reagents
(GE Healthcare Company). For (-)viRNA analysis, the membranes were hybridized with
synthesized oligo DNA probes, which have the same polarity of FHV RNA1 and were labeled
using DIG kit (Roche Company), in the hybridization buffer. Sequence for oligo probes used for
the detection of miR-58 is ATTGCCGTACTGAACGATCTCA.
2.6 RSD-2 Functional Rescue Experiment
The RSD-2 functional rescue was carried out by injecting the rsd-2 mutants (tm1429)
carrying the FR1gfp replicon with the Psur-5::RSD-2 construct. The F1 progenies were then
examined for GFP expression after being maintained at 25 °C for 36 hours post induction of the
FR1gfp replicon replication. In the F1 progenies that carry the wild type rsd-2 extrachromosomal
array, complete loss or significant reduction of green fluorescence expression was considered as
successful rsd-2 functional rescue.
2.7 Imaging Microscopy
GFP fluorescence images were collected using an AmScope MT1000 camera mounted on
an Olympus IMT-2 microscope.
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CHAPTER THREE: STRATEGIES TO STUDY RDVI IN C. ELEGANS
AND RESULTS
3.1 Initiate FHV Replication in C. elegans
The FHV replication in C. elegans was initiated using a strategy illustrated in Figure 3.1.
It has been shown that Northern blot hybridizations could detect high level accumulation of FHV
RNA1 and RNA3 in worms carrying the FR1-3 transgene described previously (Lu, Maduro et
al. 2005).

Figure 3.1 Strategy to trigger FHV replication in C. elegans. Heat induction can activate the
promoter of the FR1 transgene so that the transcription of the following sequence will be driven.
Then the ribozyme will be produced. After the ribozyme cleaves itself, the FHV plus strand will
be produced and translated to FHV RdRP. Next, with the help of FHV RdRPs, the transgenic
FHV will be able to replicate.

The high level accumulation of viral RNAs detected in transgenic worm strains arouse
from active RNA replication because in the absence of RNA replication the initial heat-induced
transcripts were below the limit of detection in worms two days post heat induction. FHV RNA2
accumulation can also be detected in FR1-3;FR2 transgenic worms after heat induction.
Therefore, detection of FHV genomic RNA1, RNA2 and subgenomic RNA3 in these worm
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strains provide strong evidences that C. elegans supports complete replication of the FHV RNA
genome (Lu, Maduro et al. 2005).
To further confirm that antiviral RNAi contributes to FHV silencing in C. elegans, FR1-3
ΔB2 transgene was introduced to well-known RNAi deficient mutant worm strains such as rde-1
mutant strain, which is very healthy, unlike many other RNAi mutant strains (Lu, Maduro et al.
2005). In contrast to undetectable accumulation of FHV RNA1 and 3 in wild type N2 worms
carrying FR1-3 ΔB2 transgene, northern blot analysis showed abundant accumulation of FHV
RNA1 and 3 in the FR1-3 ΔB2 transgenic rde-1 mutant strain (Lu, Maduro et al. 2005). Thus,
the mutant FHV RNA1 produced from FR1-3 ΔB2 transgene is not defective in self-replication,
suggesting that the decreased accumulation of FHV RNA1 and 3 in N2 worms resulted from
induction and clearance of viral RNAs by antiviral silencing in an rde-1-dependent siRNA
pathway. Taken together, all these evidences confirmed that antiviral RNAi contributes to FHV
silencing in C. elegans, making FHV transgenic C. elegans strains ideal model system to study
the antiviral RNAi.
3.2 Identify Genes Required for Antiviral RNAi in C. elegans by Feeding RNAi
Previously, a derivative of the infectious full-length cDNA clone of FHV RNA1, FR1gfp
(Li, Li et al. 2004), in which the B2 coding sequence is replaced by GFP coding sequence has
been shown to replicate autonomously and produce green fluorescence (Figure 3.2). The inserted
GFP coding sequence fused with the N-terminal 23 codons of B2 is expressed only from the
recombinant RNA3 produced during FR1gfp replication, but not directly from FR1gfp because
its initiation codon is more than 2.7 kb away from the 5’-terminus of FR1gfp RNA (Figure 3.2).
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FR1gfp is defective in RNAi suppression because of the loss of B2 production but not in
replication.

Figure 3.2 Strategy to identify genes required for antiviral RNAi in C. elegans. In the
FR1gfp transgene, GFP sequence was used to replace part of RNA3 sequence so that FHV
replication levels can be visualized. Next, feeding RNAi was used to down-regulate specific C.
elegans genes. In the normal condition, after heat induction FHV would not replicate well in the
absence of RNAi suppressor B2, while in case the C. elegans antiviral RNAi system does not
function appropriately either, the FHV transgenic viruses should restore their ability to replicate;
thus, through comparing the GFP expression levels of the worms, the antiviral RNAi gene
components can be selected out.

As a result, the FR1gfp replication and gfp expression from the FHV replicon occur only
after antiviral RNAi is suppressed by either B2 co-expression or genetic disruption of the
antiviral RNAi pathway in both cultured fruit fly and mosquito cells (Li, Li et al. 2004). To
develop a model for genetic screens to identify new genetic components in antiviral RNAi, we
generated C. elegans strains bearing a chromosomally integrated FR1gfp transgene under the
control of a heat-inducible promoter (Figure 3.2).
We found that very little green fluorescence was observed in FR1gfp worms after the heat
induction of the FHV replicon transgene (Figure 3.3 top left). In contrast, bright green
fluorescence was observed throughout the worm body after FR1gfp transgenic worms were fed
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on E. coli food that expresses rde-1 dsRNA (Figure 3.3 top middle), which depletes the mRNA
of rde-1 in a process called feeding RNAi (Timmons, Court et al. 2001). Bright green
fluorescence was also observed in FR1gfp worms after a loss-of-function rde-1 allele was
introduced into FR1gfp worms by genetic crosses (Lu, Yigit et al. 2009). Northern blot
hybridizations confirmed the abundant accumulation of the chimeric FHV RNA1 and RNA3 in
FR1gfp worms after rde-1 depletion, but FR1gfp replication was inhibited in wild-type N2
worms (Lu, Yigit et al. 2009). Thus, productive FR1gfp replication and abundant GFP
expression in FR1gfp transgenic worms depend on the genetic disruption of the antiviral RNAi
pathway, suggesting that FR1gfp transgenic worms could be used to screen for new genetic
components in the antiviral RNAi pathway by feeding RNAi (Lu, Yigit et al. 2009). Rsd-2 was
identified as one of the candidates using this strategy (Figure 3.3).

Figure 3.3 Rsd-2 was screened out as a gene required for antiviral RNAi in C. elegans (Lu,
Yigit et al. 2009). Green fluorescence was detected in FR1gfp transgeneic worms after feeding
RNAi targeting specific genes or the commonly used L4440 vector. Photographs were taken 48
hours after induction of the replicon replication.
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3.3 Rsd-2 Is Required for Antiviral RNAi in C. elegans
3.3.1 Rsd-2 Is Required for RNAi Targeting FHV in C. elegans
To confirm that rsd-2 is indeed required for RDVI, the FR1gfp replicon transgene was
introduced to rsd-2 mutants containing different alleles through genetic crosses. After heat
induction, the rsd-2 mutant strains showed the similar brightness of GFP as the drh-1 mutant
strain which is defective in RDVI (Lu, Yigit et al. 2009) (Figure 3.4A, compare the top two with
the right bottom), suggesting that rsd-2 is indeed required for RDVI targeting FR1gfp. Northern
blot hybridization further confirmed that FHV accumulates to similar levels in rsd-2 mutants as
those in drh-1 mutants (Figure 3.4B). All these observations confirmed that rsd-2 is indeed a
gene required for RDVI in C. elegans.

Figure 3.4 Rsd-2 is required for RDVI targeting FHV in C. elegans. (A) Detection of green
fluorescence in FR1gfp transgenic worms 48 hours after induction of the replicon replication. (B)
Accumulation of FR1gfp genomic (RNA1) and subgenomic RNA (RNA3) by northern blotting
in FR1gfp transgenic worms 48 hours post heat induction. Methylene blue staining of total RNA
was provided to show equal loading.
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3.3.2 Rsd-2 Is Required for RDVI Targeting Orsay Virus in C. elegans
Orsay virus is a natural viral pathogen of C. elegans. To find out whether rsd-2 is a gene
required for RDVI under natural condition, we inoculated wild type N2 worms, rsd-2 mutants
containing distinct alleles (tm1429 and pk3307), and drh-1 mutants with Orsay virus. As shown
in Figure 3.5, Orsay virus accumulated to high levels in rsd-2 mutants and drh-1 mutants but low
levels in the wild type N2 worms (Figure 3.5A, compare the lane 2, 3 and 4 with the lane 1). RTPCR detection also confirmed the high-level accumulation of Orsay virus in rsd-2 mutants
(Figure 3.5B). Taken together, these results confirmed that rsd-2 is required for RDVI under
natural condition.

Figure 3.5 Rsd-2 is required for RDVI targeting Orsay virus in C. elegans. (A) Detection of
the Orsay virus genomic RNA1 accumulation levels by northern blotting in the worms grown on
Orsay virus particle containing food for 2-3 days. Methylene blue staining of total RNA was
provided to show equal loading. (B) Confirmation of the Orsay virus replication in worms by
using RT-PCR to get two different DNA segments which were transcribed reversely from Orsay
viral RNAs, using two different pairs of primers. Following RT-PCR, DNA gel electrophoresis
was preformed and photographed. The sizes of these two DNA fragments are 1.2 and 1.3 kb
respectively.
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3.3.3 Wild Type rsd-2 Can Rescue RDVI in rsd-2 Knockout Mutants
To further confirm that it is the rsd-2 null alleles, but not any other null alleles, that are
responsible for the loss of RDVI in the rsd-2 mutants used in the test described in Figure 3.5, we
checked FR1gfp replication in rsd-2 mutants (tm1429) transgenic for Psur-5::RSD-2 (Materials
and Methods 2.2). We reasoned that if it were the rsd-2 null alleles, but not any other null alleles,
that are responsible for the loss of RDVI in the rsd-2 mutants, ectopic expression of wild type
RSD-2 coding sequence in the rsd-2 mutants will restore RDVI.
To test this hypothesis, the wild type rsd-2 expressing construct (Psur-5::RSD-2) was coinfected with an mCherry reporter construct, which directs mCherry expression in pharynx, into
the rsd-2 mutants carrying the FR1gfp replicon transgene. Since, in most cases, the
extrachromosomal arrays produced through gonad injection can only be randomly passed on to
the next generation, as a result, within each generation of the transgenic lines, there are worms
that do not carry the extrachromosomal arrays thus can serve as internal negative control. As
shown in Figure 3.6A, within each transgenic line, clear correlation between reduced GFP
expression and red fluorescence in pharynx produced by the reporter transgene was observed,
suggesting that ectopic expression of wild type RSD-2 coding sequence restored RDVI in the
rsd-2 knockout mutants.
As a reconfirmation, we checked FR1gfp replication in the chromosomal integrants
corresponding to the wild type rsd-2 transgene using northern blot. We observed that, in contrast
to the high-level replication of FR1gfp in the rsd-2 mutants, the FR1gfp replication was
significantly suppressed in rsd-2 mutants containing the integrated transgenes corresponding to
the wild type RSD-2 coding sequence (Figure 3.6B). These observations together confirmed that
it is the rsd-2 null alleles that results in the loss of antiviral silencing in the rsd-2 mutants.
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Figure 3.6 Wild type rsd-2 gene rescued RDVI in rsd-2 mutants carrying the FR1gfp
transgene. (A) Detection of green fluorescence in FR1gfp transgenic worms with and without
the extrachromosomal array that has copies of wild type rsd-2 gene which rescue a loss-offunction mutation in the endogenous copies of rsd-2 48 hours after induction of the replicon
replication. The array also expresses mCherry as a marker gene, from the mal2::mCherry
construct in which mal2 is a promoter that only functions in the pharyngeal muscle cells of C.
elegans and mCherry is a protein that can emit red fluoresence. Based on which animal’s
pharynx shows red under the fluorescence microscope, the marker allows us to differentiate
which animal contains the extrachromosomal array and which animal does not. (B)
Accumulation of FR1gfp genomic (RNA1) and subgenomic RNA (RNA3) by northern blotting
in the FR1gfp transgenic N2, rsd-2 mutant, rsd-2 mutant carrying integrated wild type rsd-2,
drh-1 mutant, and rsd-2 mutant carrying non-integrated wild type rsd-2 worms 48 hours post
heat induction. Methylene blue staining of total RNA was provided to show equal loading.
3.3.4 Rsd-2 Is Not Required for viRNA Biogenesis
Rsd-2 was originally identified as a host factor responsible for systemic spreading of RNAi
in C. elegans (Tijsterman and Plasterk 2004). Currently, how rsd-2 contributes to RDVI remains
largely unknown. As an effort to address this question, we decided to determine whether rsd-2 is
required for viRNA biogenesis. To this end, the small RNAs from N2, rrf-1, rde-1, rde-4, drh-1
and rsd-2 strains were extracted and northern blot hybridizations were performed to check the
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viRNA levels in these strains. We probed for viRNAs of the antigenomic polarity, instead of
viRNAs of genomic polarity, because probing for viRNAs of the genomic polarity resulted in a
smear and no discrete bands were detected in any of the worm strains tested either before or after
transcriptional induction of FR1gfp (Lu, Yigit et al. 2009).

Figure 3.7 ViRNAs accumulated in the rsd-2 mutants. Analysis of the (-)viRNAs
accumulation levels in the FR1gfp transgenic wild type and single knockout worm mutants 48
hours post heat induction. 15 µg of total small RNAs was loaded in each lane. DIG-labeled DNA
oligos complementary to viRNA and miRNA were used as the probes. The same membrane was
probed for miR-58 after stripping as the loading control.

The viRNAs were undetectable in wild-type worms, which may be due to the viral
replication inhibition and thus lower levels of viral dsRNA for dicing in these worms. However,
we detected viRNAs in the rsd-2 strains (Figure 3.7), indicating that the rsd-2 gene is
dispensable for viRNA biogenesis.
3.4 Delineate an rsd-2-dependent Genetic Pathway That Contributes to RDVI in C. elegans
The predominant model for antiviral silencing is the canonical dsRNA-siRNA pathway of
RNAi, which is initiated by viral double-stranded replicating intermediates. The Sole RNase III
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enzyme Dicer of C. elegans will cleave the viral dsRNAs into primary viRNAs, which will be
loaded into the RISC complex and direct the silencing of viral transcripts. The RdRP in C.
elegans can use the cleaved viral RNAs as templates to produce secondary viRNAs, which can
be further used to silence viral transcripts, so that antiviral RNAi effects can be amplified. The
followings are some discoveries on the antiviral RNAi pathway in C. elegans. First, the
observation that Dicer was required for anti-VSV in C. elegans cells (Schott, Cureton et al. 2005)
suggests that Dicer is required for antiviral silencing in C. elegans. Second, dsRNA-binding
proteins (dsRBPs) are also required by Dicer to play its role in RNAi. For example, in the
exogenous dsRNA initiated RNAi (exo-RNAi) pathway in C. elegans, the dsRBP, RDE-4,
cooperates with Dicer during cleaving long dsRNAs to siRNAs, although it is not essential in the
following steps (Parker, Eckert et al. 2006). Furthermore, RDE-4 was found to be required for
viRNAs biogenesis in the RDVI pathway of C. elegans (Lu, Yigit et al. 2009). Third, a DEXHbox helicase protein DRH-1 and an Argonaute protein RDE-1 were pulled down together with
RDE-4 and DCR-1 in the exo-RNAi pathway in C. elegans, through immunoprecipitation
(Tabara, Yigit et al. 2002), suggests that DCR-1, RDE-4, DRH-1, and RDE-1 may interact with
each other to function in the exo-RNAi pathway in C. elegans. What’s more, DRH-1 and RDE-1
were found as requirements for activity of viRNAs, and both were found working downstream of
RDE-4 in RDVI in C. elegans (Lu, Yigit et al. 2009). Fourth, Dicer-related helicase protein
DRH-2 and Argonaute protein ERGO-1 were found as negative regulators of antiviral RNAi in
C. elegans (Lee and Sinko 2006; Lu, Yigit et al. 2009).
To determine the genetic pathway that involves rsd-2, six double mutants carrying FR1gfp
transgene by genetic crosses, rsd-2;rde-4, rsd-2;drh-1, rsd-2;rde-1, rsd-2;rrf-1, rsd-2;drh-2, rsd2;ergo-1 were created. We observed that both FHV and Orsay virus replication levels in the rsd24

2;rde-4 and rsd-2;drh-1 double mutants were enhanced compared to corresponding single
mutants, suggesting that rsd-2 works in an RDVI pathway different from that involves rde-4 and
drh-1. In contrast to the discovery of no viRNAs detected in the rde-4 single mutants and rde4;drh-1 double mutants (Lu, Yigit et al. 2009), we found viRNAs accumulated in the rsd-2;rde-4
double mutants, further corroborating our conclusion that rsd-2 works in an rde-4-independent
RDVI pathway. Furthermore, our observations that both FHV and Orsay virus replication levels
were not enhanced in rsd-2;rrf-1 double mutants, suggested rsd-2 and rrf-1 may function in the
same RDVI pathway. In addition, our detection that both FHV and Orsay virus replication level
were decreased in rsd-2;drh-2 and rsd-2;ergo-1 double mutants, further confirmed both drh-2
and ergo-1 negatively regulate rde-4-dependent RDVI pathway in C. elegans .
3.4.1 Both FHV and Orsay Virus Replication Were Enhanced in rsd-2;rde-4 Double
Mutants Compared to Either rsd-2 or rde-4 Single Mutants

To investigate the rsd-2-dependent genetic pathway in C. elegans, FR1gfp transgene was
introduced to rsd-2;rde-4 double mutants through genetic crosses. After heat induction of the
FR1gfp transgenic N2, rde-4, rsd-2, and rsd-2;rde-4 strains, the GFP expression level in the rsd2;rde-4 double mutants was found to be enriched compared to respective single mutants (Figure
3.8, compare picture 4 with 2 and 3), indicating that FHV replication level in the rsd-2;rde-4
double mutants was enhanced compared to either rsd-2 or rde-4 single mutants.
Total RNAs were extracted from all of the above four heat inducted strains, and northern
blot hybridizations were performed to check FHV replication levels. We observed FHV
replication level was enhanced in rsd-2;rde-4 double mutants (Figure 3.9A, compare the lane 4
with 2 and 3), demonstrating a further loss of RDVI in rde-4;rsd-2 double mutants compared to
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either rde-4 or rsd-2 single mutants. This result indicated that FHV was targeted by two parallel
antiviral RNAi pathways in C. elegans and that rsd-2 works in an rde-4-independent antiviral
RNAi pathway.

Figure 3.8 GFP expression level was enhanced in rsd-2;rde-4 double mutants. Detection of
green fluorescence in the FR1gfp transgenic wild type, single and double knockout worm
mutants 48 hours post replicon replication.

Figure 3.9 FHV and Orsay virus replication levels were enhanced in rsd-2;rde-4 double
mutants. (A) Accumulation of the FR1gfp replicon RNAs in wild type, single and double
knockout worm mutants 48 hours after replicon replication. (B) Accumulation of the Orsay virus
RNA1 in wild type, single and double knockout worm mutants after growing them on Orsay
virus particle containing food for 3 days.
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To further confirm our conclusion that rsd-2 works in a separate antiviral RNAi pathway
compared to rde-4, we used Orsay virus to infect the N2, rde-4, rsd-2, and rsd-2;rde-4 mutant
strains for 2 days, and then total RNAs were extracted for northern blot analyses. We observed
Orsay virus replication level in rsd-2;rde-4 double mutants was enhanced (Figure 3.9B, compare
the lane 4 with 2 and 3), further reinforcing our conclusion that rsd-2 functions in an antiviral
RNAi pathway that does not involve rde-4.
3.4.2 Both FHV and Orsay Virus Replication Were Enhanced in rsd-2;drh-1 Double
Mutants Compared to Corresponding Single Mutants

If rsd-2 indeed works in a separate antiviral RNAi pathway, both FHV and Orsay virus
replication should be enhanced in rsd-2;drh-1 double mutants because drh-1 is known to
function downstream of rde-4 down the same genetic pathway. To test this hypothesis, FR1gfp
transgene was introduced to rsd-2;drh-1 double mutants through genetic crosses. After heat
inducting the FR1gfp transgenic N2, drh-1, rsd-2, and rsd-2;drh-1 strains, the GFP expression
level was shown enhanced in rsd-2;drh-1 double mutants compared to either rsd-2 or drh-1
single mutants (Figure 3.10, compare image 4 with 2 and 3), implying that FHV replication was
enhanced in the rsd-2;drh-1 double mutants.
Total RNAs were extracted from the heat inducted strains for northern blot hybridizations
to check FHV replication levels. The observation that FHV replication level was enhanced in
rsd-2;drh-1 double mutants (Figure 3.11A, compare the lane 4 with 2 and 3) further upheld our
conclusion that rsd-2 functions in an antiviral RNAi pathway that does not involve rde-4 or drh1.
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Figure 3.10 Rsd-2 and drh-1 function in separate RDVI pathways. Detection of green
fluorescence in the FR1gfp transgenic wild type, single and double knockout worm mutants 48
hours post replicon replication.

As a reconfirmation, we used Orsay virus to infect the N2, rde-4, drh-1, and rsd-2;drh-1
mutants for 2 days, and then total RNAs were extracted for northern blot analyses. Our
observation that Orsay virus replication level in rsd-2;drh-1 double mutants was enhanced
(Figure 3.11B, compare the lane 4 with 2 and 3) compared to each single mutants once again
confirmed rsd-2 functions in a genetic pathway that does not involve rde-4 and drh-1.

Figure 3.11 FHV and Orsay virus replication levels were enhanced in drh-1;rsd-2 double
mutants. (A) Accumulation of the FR1gfp replicon RNAs in wild type, single and double
knockout worm mutants 48 hours after replicon replication. (B) Accumulation of the Orsay virus
RNA1 in wild type, single and double knockout worm mutants after growing them on Orsay
virus particle containing food for 3 days.
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3.4.3 Both FHV and Orsay Virus Replication Levels Were Enhanced in rsd-2;rde-1 Double
Mutants Compared to Either rsd-2 or rde-1 Single Mutants

Rde-1 encodes an Argonaute protein that functions downstream of siRNA biogenesis in
RNAi. To find out whether rsd-2 and rde-1 function in the same genetic pathway, FR1gfp
transgene was introduced to rsd-2;rde-1 double mutants by genetic crosses. After heat induction
of the FR1gfp transgenic N2, rde-1, rsd-2, and rsd-2;rde-1 strains, the GFP expression level was
shown enhanced in rsd-2;rde-1 double mutants compared to either single mutants (Figure 3.12,
compare picture 4 with picture 2 and 3), suggesting that FHV replication level was enhanced in
the rsd-2;rde-1 double mutants.

Figure 3.12 GFP expression level was enhanced in rsd-2;rde-1 double mutants. Detection of
green fluorescence in the FR1gfp transgenic wild type, single and double knockout worm
mutants 48 hours post replicon replication.

Northern blot hybridization also confirmed that FHV accumulated to higher levels in rsd2;rde-1 double mutants than those in either rde-1 or rsd-2 single mutants (Figure 3.13A,
compare lane 4 with lane 2 and 3). Thus, we concluded rsd-2 and rde-1 function in separate
antiviral RNAi pathways.
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To affirm this conclusion, Orsay virus was used to infect the N2, rsd-2, rde-1, and rsd2;rde-1 mutant strains for 2 days, and then total RNAs were extracted and northern blot
hybridizations were performed to check the Orsay virus replication levels. The observations that
the Orsay virus replication level in rsd-2;rde-1 double mutants was enhanced compared to either
single mutants (Figure 3.13B, compare lane 4 with 2 and 3) further bolstered our conclusion that
rsd-2 and rde-1 work in separate antiviral RNAi pathways.

Figure 3.13 FHV and Orsay virus replication levels were enhanced in rsd-2;rde-1 double
mutants. (A) Accumulation of the FR1gfp replicon RNAs in wild type, single and double
knockout worm mutants 48 hours after replicon replication. (B) Accumulation of the Orsay virus
RNA1 in wild type, single and double knockout worm mutants after growing them on Orsay
virus particle containing food for 3 days.
3.4.4 ViRNAs Accumulated in rsd-2;rde-4 Double Mutants
It is known that rde-4 is responsible for viRNA biogenesis in its antiviral RNAi pathway
based on the observation of no viRNAs detected in rde-4 single mutants (Lu, Yigit et al. 2009)
and that rsd-2 is not required for viRNA biogenesis based on the observation of viRNAs
accumulation in rsd-2 single mutants compared to wild type strain. Thus, if it is true that rsd-2
works in a different antiviral RNAi pathway from rde-4 and drh-1, then viRNAs would
accumulate in rsd-2;rde-4 double mutants because mutant rde-4 should not affect the viRNA

30

biogenesis of the antiviral RNAi pathway in which rsd-2 involves and mutant rsd-2 does not
affect the viRNA biogenesis of its own antiviral RNAi pathway since rsd-2 gene is dispensable
for viRNA biogenesis.
That northern blot hybridization analysis detected viRNAs accumulated to high levels in
rsd-2;rde-4 double mutants (Figure 3.14), further substantiated rsd-2 works in an rde-4
independent antiviral RNAi pathway.

Figure 3.14 ViRNAs accumulated in rsd-2;rde-4 double mutants. Analysis of the (-)viRNAs
accumulation levels in the FR1gfp transgenic double knockout worm mutants 48 hours post heat
induction. 15 µg of total small RNAs was loaded in each lane. DIG-labeled DNA oligos
complementary to viRNA and miRNA were used as the probes. The same membrane was probed
for miR-58 after stripping as the loading control.
3.4.5 Neither FHV nor Orsay Virus Replication Levels in rsd-2;rrf-1 Double Mutants Were
Enhanced Compared to Those in rsd-2 Single Mutants

To investigate the antiviral RNAi pathway that involves rsd-2, FR1gfp transgenic rsd2;rrf-1 double mutants were constructed through genetic crosses. Northern blot analyses showed
that both FHV and Orsay virus replicated to similar levels in rsd-2;rrf-1 double mutants as those
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in rsd-2 single mutants (Figure 3.15, compare lane 3 with 4), suggesting rsd-2 and rrf-1 may
work in the same genetic pathway for antiviral RNAi.

Figure 3.15 FHV and Orsay virus replication levels in rsd-2;rrf-1 double mutants were
similar to those in rsd-2 single mutants. (A) Accumulation of the FR1gfp replicon RNAs in
wild type, single and double knockout worm mutants 48 hours after replicon replication. (B)
Accumulation of the Orsay virus RNA1 in wild type, single and double knockout worm mutants
after growing them on Orsay virus particle containing food for 3 days.
3.4.6 Both FHV and Orsay Virus Replication Levels Were Decreased in the rsd-2;drh-2
Double Mutants Compared to Those in rsd-2 Single Mutants

To investigate the rsd-2-dependent genetic pathway for antiviral RNAi, we constructed
FR1gfp transgenic rsd-2;drh-2 double mutants by genetic crosses. The observations that both
FHV and Orsay virus replicated to lower levels in rsd-2;drh-2 double mutants compared to those
in rsd-2 single mutants (Figure 3.16, compare lane 3 with 4), indicating the drh-2 mutant allele
enhanced antiviral RNAi in the mutant rsd-2 background. This finding confirmed that the rde-4dependent RDVI pathway was targeted by drh-2 for negative regulation.
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Figure 3.16 FHV and Orsay virus replication levels were decreased in rsd-2;drh-2 double
mutants compared to those in rsd-2 single mutants. (A) Accumulation of the FR1gfp replicon
RNAs in wild type, single and double knockout worm mutants 48 hours after replicon
replication. (B) Accumulation of the Orsay virus RNA1 in wild type, single and double knockout
worm mutants after growing them on Orsay virus particle containing food for 3 days.
3.4.7 Both FHV and Orsay Virus Replication Levels Were Decreased in rsd-2;ergo-1
Double Mutants Compared to Those in rsd-2 Single Mutants

To determine the rsd-2-denpendent genetic pathway for antiviral RNAi, we also
constructed FR1gfp transgenic rsd-2;ergo-1 double mutants by genetic crosses. We found that
the accumulations of both FHV and Orsay virus were decreased in rsd-2;ergo-1 double mutants
compared to those in rsd-2 single mutants (Figure 3.17, compare lane 3 and 4), indicating that
the ergo-1 mutant allele enhanced antiviral RNAi function in the rsd-2 mutants. This result
confirmed that the rde-4-dependent RDVI pathway was also targeted by ergo-1 for negative
regulation.
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Figure 3.17 FHV and Orsay virus replication levels were decreased in rsd-2;ergo-1 double
mutants compared to those in rsd-2 single mutants. (A) Accumulation of the FR1gfp replicon
RNAs in wild type, single and double knockout worm mutants 48 hours after replicon
replication. (B) Accumulation of the Orsay virus RNA1 in wild type, single and double knockout
worm mutants after growing them on Orsay virus particle containing food for 3 days.
3.5 Other Biological Functions of rsd-2 in C. elegans
3.5.1 Transgene Can Be Silenced by viRNAs in the rsd-2 Mutant Strain
To test whether rsd-2 is required for transgene silencing mediated by viRNAs, we
developed several FR1fp;gfp transgenic strains that contain both an FR1fp replicon transgene
and a gfp transgene. The FR1fp replicon transgene is the same as the FR1gfp except that the 3’
end of the gfp sequence was used to substitute for the whole gfp sequence. GFP expression
levels were examined 48 hours post heat induction of the transgenic N2, rsd-2, and drh-1 mutant
strains, and we found that FR1fp replicon replicated in the rsd-2 mutant strain and GFP
expression of this strain was suppressed accordingly (Figure 3.18). This result demonstrated that
viRNAs produced from the FR1fp replicon were able to silence gfp transgene in the absence of
the rsd-2 gene. We thus concluded that rsd-2 is not essential for transgene silencing mediated by
viRNAs.
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Figure 3.18 Rsd-2 is not important for viRNAs mediated transgene silencing. (A) FHV
replication levels in the FR1fp;gfp transgenic worms 48 hours post heat induction. (B) GFP
expression levels in the FR1fp;gfp transgenic worms 48 hours post heat induction.
3.5.2 GFP Was Silenced in the FR1fp; gfp;rsd-2 Mutant Strain by Exogenous GFP dsRNA
To test whether rsd-2 plays a role in RNAi triggered by artificial dsRNAs, a process often
been referred to classical RNAi, feeding RNAi strategy was used to check whether feeding the
FR1fp;gfp;rsd-2 mutant strain with the E. coli food producing the GFP dsRNA can downregulate GFP expression of this strain.

Figure 3.19 GFP was silenced in the rsd-2 mutant strain. (A) GFP expression levels of the
worms fed with the regular E. coli strain. (B) GFP expression levels of the worms which were
fed with the GFP dsRNA producing E. coli strain for 24 hours and 48 hours.
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After 24 and 48 hours feeding RNAi treatment, we found both green fluorescence and
northern blot hybridization showed silencing of GFP expression in the FR1fp;gfp;rsd-2 mutant
strain (Figure 3.19B), suggesting that rsd-2 is dispensable for artificial dsRNA triggered RNAi in
C. elegans. This test further suggested that antiviral RNAi and classical RNAi pathways in C.
elegans are genetically distinct although they share some genetic components such as DCR-1,
RDE-1 and RDE-4.
3.5.3 Rsd-2 Is Not Required for miRNA Biogenesis
To test whether rsd-2 is involved in miRNA mediated RNAi pathway, total small RNAs
were extracted from the rsd-2 mutant strain and northern blot hybridization analyses were
performed. The observation that miRNA-58 expression levels were similar between the wild
type N2 and mutant rsd-2 strains (Figure 3.20) suggested that miRNA expression levels were not
affected in rsd-2 mutants because miR-58 is one of the representative miRNAs of C. elegans.
Together with our observation that the rsd-2 mutant strain did not show any development defect,
we concluded that rsd-2 is dispensable for miRNA biogenesis or function.

Figure 3.20 MiRNA-58 expression levels were not affected in rsd-2 mutants. Analysis of the
miRNAs expression levels in wild type, single and double knockout worm mutants. 15 µg of
total small RNAs was loaded in each lane. DIG-labeled DNA oligos complementary to miRNA
were used as the probes. Ethidium bromide staining of tRNAs was provided to show equal
loading.
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CHAPTER FOUR: CONCLUSIONS
The observations that both Orsay and FHV viruses accumulated to high level in rsd-2
knockout mutants and that the wild type rsd-2 gene can readily rescue the antiviral silencing in
rsd-2 mutants confirmed rsd-2 is the gene required for antiviral silencing in C. elegans.
The fact that FHV replicon replicated to a much higher level in the rsd-2;rde-4 double
mutants compared to that in corresponding single mutants indicates that rsd-2 and rde-4 work in
separate genetic pathways for antiviral silencing in C. elegans. Consistent with this observation,
viRNAs were detected in rde-4;rsd-2 double mutants and rsd-2 single mutants, but not in rde-4
mutants.
We detected the FHV RNA1 and RNA3 accumulation and the FHV-specific viRNAs of
the antigenomic polarity, (-)viRNAs, in rsd-2 mutants. This is in sharp contrast to the fact that no
viRNAs were detected in rde-4 mutants. These observations ruled out a direct role of rsd-2 gene
in virus sensing or viRNA biogenesis. Since the high-level accumulation of (-)viRNAs in rsd-2
mutants failed to inhibit the replication level of the FHV replicon suggests that rsd-2 is essential
for activity of viRNAs.
We found that the FHV replicon replicated to lower level in rsd-2;drh-2 double mutants
compared to that in rsd-2 single mutants. This result showed that the drh-2 null allele enhanced
antiviral silencing when rde-4-mediated antiviral silencing was functional, substantiating that the
rde-4-initiated antiviral silencing pathway was targeted by drh-2 for negative regulation. By
analog, we believe ergo-1 also negatively regulates the rde-4-mediated antiviral silencing.
Based on these findings, we conclude that rsd-2 is required for antiviral silencing in C.
elegans, by contributing to rde-4-independent antiviral silencing. The fact that viRNAs can still
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be detected in rsd-2 mutants suggests that rsd-2 is required for function, but not the biogenesis,
of viRNAs.
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CHAPTER FIVE: DISCUSSIONS
Prior research has demonstrated that viruses can infect and replicate in C. elegans and their
replication can trigger RDVI (Lu, Maduro et al. 2005; Schott, Cureton et al. 2005; Wilkins,
Dishongh et al. 2005; Liu, Lin et al. 2006). These findings suggest that C. elegans could become
an important model for understanding basic aspects of virus–host interactions. In this work, we
discovered that (i) the antiviral silencing induced by either FHV or Orsay virus requires rsd-2, (ii)
the production of FHV siRNAs in the rsd-2 mutant strain is rde-4-independent, and (iii) rsd-2 is
not essential for the sensing or biogenesis of viRNAs. These findings suggested a role of rsd-2 in
an rde-4 independent antiviral silencing pathway. In addition, my study also demonstrated that
rsd-2 does not play important roles in miRNA, exo-RNAi, or viRNA mediated silencing of
cellular transcripts, suggesting a virus-specific function.
Rsd-2 Is One of the Genetic Requirements of Antiviral RNAi in C. elegans
Our study confirmed that rsd-2 is one of the known RNAi factors that contribute to worm
RDVI. The fact that the antiviral silencing against FHV and Orsay virus was further enhanced in
both drh-2 and ergo-1 mutant worms but decreased in both rsd-2;drh-2 and rsd-2;ergo-1 double
mutants confirmed that drh-2 and ergo-1 are negative regulators of antiviral silencing in C.
elegans.
C. elegans RSD-2 May Control the Target Specificity of Distinct siRNA Pathways
Several lines of evidence suggested that rsd-2 has a specific role in the rde-4-independent
antiviral RNAi pathway in C. elegans. First, a further loss of the worm antiviral RNAi against
both FHV and Orsay virus was observed in rsd-2;rde-4, rsd-2;drh-1 double mutants compared to
either single mutants, indicating that rsd-2 and rde-4 work in separate antiviral RNAi pathways
in C. elegans. Second, viRNAs, which are undetectable in rde-4 single mutants, became
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detectable in rsd-2;rde-4 double mutants, suggesting that the production of viRNAs in the rsd-2
mutant strain occurs in an rde-4-independent manner. This observation further confirmed rsd-2
regulates a distinct siRNA pathway.
RSD-2 Contributes to the Function of viRNAs in Worm Antiviral RNA Silencing
The observation that viRNAs could be detected in the rsd-2 mutants carrying the FR1gfp
transgene suggested that rsd-2 is not essential for viRNA biogenesis in the antiviral RNAi
pathway and that rsd-2 does not play a critical role in the sensing of the viral dsRNA triggers.
Thus, rsd-2 could act downstream of both steps of sensing viral dsRNA triggers and processing
viral dsRNA triggers into viRNAs. Because an RNAi factor can contribute to virus sensing,
viRNA biogenesis or function of viRNAs, we believe that rsd-2 is required for the function of
viRNAs.
Uniqueness of RSD-2 in C. elegans
So far, no RSD-2 homologue has been identified in other organisms, suggesting the
uniqueness of RSD-2 mediated RDVI in C. elegans.

40

REFERENCES
1. (1998). "Genome sequence of the nematode C. elegans: a platform for investigating
biology." Science 282(5396): 2012-2018.
2. Albert, P. S. and D. L. Riddle (1988). "Mutants of Caenorhabditis elegans that form
dauer-like larvae." Developmental biology 126(2): 270-293.
3. Aliyari, R. and S.-W. Ding (2009). "RNA-based viral immunity initiated by the Dicer
family of host immune receptors." Immunological Reviews 227(1): 176-188.
4. Aoki, K., H. Moriguchi, et al. (2007). "In vitro analyses of the production and activity of
secondary small interfering RNAs in C. elegans." Embo J 26(24): 5007-5019.
5. Bass, B. L. (2000). "Double-stranded RNA as a template for gene silencing." Cell 101(3):
235-238.
6. Bernstein, E., A. A. Caudy, et al. (2001). "Role for a bidentate ribonuclease in the
initiation step of RNA interference." Nature 409(6818): 363-366.
7. Boutet, S., F. Vazquez, et al. (2003). "Arabidopsis HEN1: a genetic link between
endogenous miRNA controlling development and siRNA controlling transgene silencing
and virus resistance." Current biology : CB 13(10): 843-848.
8. Cassada, R. C. and R. L. Russell (1975). "The dauerlarva, a post-embryonic
developmental variant of the nematode Caenorhabditis elegans." Developmental biology
46(2): 326-342.
9. Deleris, A., J. Gallego-Bartolome, et al. (2006). "Hierarchical action and inhibition of
plant Dicer-like proteins in antiviral defense." Science 313(5783): 68-71.
10. Diaz-Pendon, J. A., F. Li, et al. (2007). "Suppression of antiviral silencing by cucumber
mosaic virus 2b protein in Arabidopsis is associated with drastically reduced
accumulation of three classes of viral small interfering RNAs." Plant Cell 19(6): 20532063.
11. Ding, S. W., H. Li, et al. (2004). "RNA silencing: a conserved antiviral immunity of
plants and animals." Virus Res 102(1): 109-115.
12. Ding, S. W. and O. Voinnet (2007). "Antiviral immunity directed by small RNAs." Cell
130(3): 413-426.
13. Duchaine, T. F., J. A. Wohlschlegel, et al. (2006). "Functional proteomics reveals the
biochemical niche of C. elegans DCR-1 in multiple small-RNA-mediated pathways."
Cell 124(2): 343-354.
41

14. Epstein, H. F., D. C. Shakes, et al. (1995). Caenorhabditis elegans modern biological
analysis of an organism. Methods in cell biology,. San Diego, Academic Press.
15. Epstein, H. F., R. H. Waterston, et al. (1974). "A mutant affecting the heavy chain of
myosin in Caenorhabditis elegans." J Mol Biol 90(2): 291-300.
16. Felix, M. A., A. Ashe, et al. (2011). "Natural and experimental infection of
Caenorhabditis nematodes by novel viruses related to nodaviruses." PLoS Biol 9(1).
17. Fire, A., S. Xu, et al. (1998). "Potent and specific genetic interference by double-stranded
RNA in Caenorhabditis elegans." Nature 391(6669): 806-811.
18. Girard, L. R., T. J. Fiedler, et al. (2007). "WormBook: the online review of
Caenorhabditis elegans biology." Nucleic Acids Res 35(Database issue): D472-475.
19. Grishok, A., A. E. Pasquinelli, et al. (2001). "Genes and mechanisms related to RNA
interference regulate expression of the small temporal RNAs that control C. elegans
developmental timing." Cell 106(1): 23-34.
20. Hammond, S. M. (2005). "Dicing and slicing: the core machinery of the RNA
interference pathway." FEBS Lett 579(26): 5822-5829.
21. Hammond, S. M., E. Bernstein, et al. (2000). "An RNA-directed nuclease mediates posttranscriptional gene silencing in Drosophila cells." Nature 404(6775): 293-296.
22. Hammond, S. M., S. Boettcher, et al. (2001). "Argonaute2, a link between genetic and
biochemical analyses of RNAi." Science 293(5532): 1146-1150.
23. Hammond, S. M., A. A. Caudy, et al. (2001). "Post-transcriptional gene silencing by
double-stranded RNA." Nat Rev Genet 2(2): 110-119.
24. Johnson, K. L. and L. A. Ball (1999). "Induction and maintenance of autonomous flock
house virus RNA1 replication." J Virol 73(10): 7933-7942.
25. Jorgensen, E. M. and S. E. Mango (2002). "The art and design of genetic screens:
caenorhabditis elegans." Nat Rev Genet 3(5): 356-369.
26. Jose, A. M. and C. P. Hunter (2007). "Transport of sequence-specific RNA interference
information between cells." Annu Rev Genet 41: 305-330.
27. Knight, S. W. and B. L. Bass (2001). "A role for the RNase III enzyme DCR-1 in RNA
interference and germ line development in Caenorhabditis elegans." Science 293(5538):
2269-2271.
42

28. Lee, S. H. and P. J. Sinko (2006). "siRNA--getting the message out." Eur J Pharm Sci
27(5): 401-410.
29. Li, H., W. X. Li, et al. (2002). "Induction and suppression of RNA silencing by an animal
virus." Science 296(5571): 1319-1321.
30. Li, W. X., H. Li, et al. (2004). "Interferon antagonist proteins of influenza and vaccinia
viruses are suppressors of RNA silencing." Proc Natl Acad Sci U S A 101(5): 1350-1355.
31. Liu, W. H., Y. L. Lin, et al. (2006). "Restriction of vaccinia virus replication by a ced-3
and ced-4-dependent pathway in Caenorhabditis elegans." Proc Natl Acad Sci U S A
103(11): 4174-4179.
32. Lu, R., M. Maduro, et al. (2005). "Animal virus replication and RNAi-mediated antiviral
silencing in Caenorhabditis elegans." Nature 436(7053): 1040-1043.
33. Lu, R., E. Yigit, et al. (2009). "An RIG-I-Like RNA helicase mediates antiviral RNAi
downstream of viral siRNA biogenesis in Caenorhabditis elegans." PLoS Pathog 5(2): 6.
34. McManus, M. T. and P. A. Sharp (2002). "Gene silencing in mammals by small
interfering RNAs." Nat Rev Genet 3(10): 737-747.
35. Mello, C. C., J. M. Kramer, et al. (1991). "Efficient gene transfer in C.elegans:
extrachromosomal maintenance and integration of transforming sequences." Embo J
10(12): 3959-3970.
36. Pak, J. and A. Fire (2007). "Distinct populations of primary and secondary effectors
during RNAi in C. elegans." Science 315(5809): 241-244.
37. Parker, G. S., D. M. Eckert, et al. (2006). "RDE-4 preferentially binds long dsRNA and
its dimerization is necessary for cleavage of dsRNA to siRNA." Rna 12(5): 807-818.
38. Parrish, S. and A. Fire (2001). "Distinct roles for RDE-1 and RDE-4 during RNA
interference in Caenorhabditis elegans." Rna 7(10): 1397-1402.
39. Riddle, D. L. (1997). C. elegans II. Plainview, N.Y., Cold Spring Harbor Laboratory
Press.
40. Rogers, A., I. Antoshechkin, et al. (2008). "WormBase 2007." Nucleic Acids Res
36(Database issue): D612-617.
41. Ruby, J. G., C. Jan, et al. (2006). "Large-scale sequencing reveals 21U-RNAs and
additional microRNAs and endogenous siRNAs in C. elegans." Cell 127(6): 1193-1207.

43

42. Schott, D. H., D. K. Cureton, et al. (2005). "An antiviral role for the RNA interference
machinery in Caenorhabditis elegans." Proc Natl Acad Sci U S A 102(51): 18420-18424.
43. Sharp, P. A. (2001). "RNA interference--2001." Genes Dev 15(5): 485-490.
44. Sijen, T., J. Fleenor, et al. (2001). "On the role of RNA amplification in dsRNA-triggered
gene silencing." Cell 107(4): 465-476.
45. Sijen, T., F. A. Steiner, et al. (2007). "Secondary siRNAs result from unprimed RNA
synthesis and form a distinct class." Science 315(5809): 244-247.
46. Stiernagle, T. (2006). "Maintenance of C. elegans." WormBook 11: 1-11.
47. Tabara, H., M. Sarkissian, et al. (1999). "The rde-1 gene, RNA interference, and
transposon silencing in C. elegans." Cell 99(2): 123-132.
48. Tabara, H., E. Yigit, et al. (2002). "The dsRNA binding protein RDE-4 interacts with
RDE-1, DCR-1, and a DExH-box helicase to direct RNAi in C. elegans." Cell 109(7):
861-871.
49. Tijsterman, M. and R. H. Plasterk (2004). "Dicers at RISC; the mechanism of RNAi."
Cell 117(1): 1-3.
50. Timmons, L., D. L. Court, et al. (2001). "Ingestion of bacterially expressed dsRNAs can
produce specific and potent genetic interference in Caenorhabditis elegans." Gene 263(12): 103-112.
51. Tomari, Y. and P. D. Zamore (2005). "Perspective: machines for RNAi." Genes Dev
19(5): 517-529.
52. Vastenhouw, N. L. and R. H. Plasterk (2004). "RNAi protects the Caenorhabditis elegans
germline against transposition." Trends Genet 20(7): 314-319.
53. Venter, P. A. and A. Schneemann (2008). "Recent insights into the biology and
biomedical applications of Flock House virus." Cell Mol Life Sci 65(17): 2675-2687.
54. Wang, X. H., R. Aliyari, et al. (2006). "RNA interference directs innate immunity against
viruses in adult Drosophila." Science 312(5772): 452-454.
55. Waterston, R. H., H. F. Epstein, et al. (1974). "Paramyosin of Caenorhabditis elegans." J
Mol Biol 90(2): 285-290.
56. Wilkins, C., R. Dishongh, et al. (2005). "RNA interference is an antiviral defence
mechanism in Caenorhabditis elegans." Nature 436(7053): 1044-1047.
44

57. Wood, W. B. (1988). The Nematode Caenorhabditis elegans. Cold Spring Harbor, N.Y.,
Cold Spring Harbor Laboratory.
58. Xie, Z., L. K. Johansen, et al. (2004). "Genetic and functional diversification of small
RNA pathways in plants." PLoS Biol 2(5): 24.

45

VITA
Rui Zhang was born and raised in Jingjiang City, Jiangsu Province of China. She attended
North China Coal Medical University majoring in pharmacy in Tangshan, China, beginning
September 1999 and she graduated in the July of 2003 with a Bachelor of Science degree. After
graduation she worked in Yangzhou Pharmaceutical Company from 2003 to 2004. She started
her graduate study majoring in pharmaceutical sciences in Huazhong University of Science and
Technology in Wuhan, China, since the September of 2005 and she graduated with a Master of
Science degree in July 2008. In 2010, Rui Zhang started her graduate study under the guidance
of Dr. Rui Lu in the Department of Biological Sciences at Louisiana State University in Baton
Rouge, Louisiana.

46

